Toggle navigation
Home
Search
Services
Blog
Contact
About
Phaseii Clinical Studies with Lhrh Agonists
Henzl, Milan
Syntex (USA), Inc.-Research Division, Palo Alto, CA, United States
Search grants from Milan Henzl
Search grants from Syntex (USA), Inc.-Research Division
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use
Interaction between DA, alpha-Synuclein and Chaperone-Mediated Autophagy
Safety, tolerability &antihypertensive efficacy of multiple dose L-753
Excellence in Science, Technology, Engineering and Mathematics Scholarship Program
Role of Collisionless Reconnection Mechanisms in Solar Flares and Coronal Mass Ejections (CMEs)
Recently added grants:
Hippocampal-orbitofrontal interactions and reward learning
Neurodevelopmental Trajectories of Reward Processing in Very Early Emerging Risk for Depression
Predictive Coding as a Framework for Understanding Psychosis
Generation of Robust Resident Memory T cells in Barrier Tissues through Skin Vaccination
Development of microfluidic blood-brain tumor barrier model to screen chemotherapeutic strategies for breast cancer brain metastases
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research and Development Contracts (N01)
Project #
N01HD032831-004
Application #
3650645
Study Section
Project Start
1983-09-30
Project End
1985-11-29
Budget Start
1985-09-30
Budget End
1985-09-29
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Syntex (USA), Inc.-Research Division
Department
Type
DUNS #
City
Palo Alto
State
CA
Country
United States
Zip Code
94304
Publications
Monroe, S E; Blumenfeld, Z; Andreyko, J L et al.
(1986)
Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin).
J Clin Endocrinol Metab 63:1334-41
Comments
Be the first to comment on Milan Henzl's grant